Effect of retroviral endostatin gene transfer on subcutaneous and intraperitoneal growth of murine tumors

Journal of the National Cancer Institute

Volumn 93, Issue 13, 2001, Pages 1014-1020

  Feldman, Andrew L ^a   Alexander, H Richard ^a   Hewitt, Stephen M ^a   Lorang, Dominique ^a   Thiruvathukal, Christina E ^a   Turner, Ewa M ^a   Libutti, Steven K ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ENDOSTATIN; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CELL LINE; CELL LYSATE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENDOTHELIUM CELL; ENZYME IMMUNOASSAY; GENE THERAPY; GENE TRANSFER; IN VIVO STUDY; LIVER CELL; MOLECULAR CLONING; MONITORING; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; RETROVIRUS; STATISTICAL ANALYSIS; SUPERNATANT; TUMOR GROWTH; TUMOR VOLUME;

EID: 0035806489     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/93.13.1014     Document Type: Article

References (35)

1. What is the evidence that tumors are angiogenesis dependent?
2. Progress in antiangiogenic gene therapy of cancer
3. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
4. Clinical studies of angiogenesis inhibitors: The University of Texas MD Anderson Center Trial of Human Endostatin
5. The pCL vector system: Rapid production of helper-free, high-titer, recombinant retroviruses
6. Antiangiogenic gene therapy of cancer utilizing a recombinant adenovirus to elevate systemic endostatin levels in mice
7. Epithelial cell culture from normal glandular tissue of mice
8. Premalignancy in vitro: Progression of an initially benign epithelial cell line to malignancy
9. Evaluation of promoter strength for hepatic gene expression in vivo following adenovirus-mediated gene transfer
10. High-level transgene expression in human hematopoietic progenitors and differentiated blood lineages after transduction with improved lentiviral vectors
11. Correspondence re: Q-R Chen et al., Liposomes complexed to plasmids encoding angiostatin and endostatin inhibit breast cancer in nude mice
12. The influence of angiogenesis research on management of patients with breast cancer
13. Continuous administration of angiostatin inhibits accelerated growth of colorectal liver metastases after partial hepatectomy
14. Continuous release of endostatin from microencapsulated engineered cells for tumor therapy
15. Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases
16. Antiangiogenic gene therapy for cancer via systemic administration of adenoviral vectors expressing secretable endostatin
17. Mouse endostatin inhibits the formation of lung and liver metastases
18. Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene
19. Liposomes complexed to plasmids encoding angiostatin and endostatin inhibit breast cancer in nude mice
20. Gene transfer into humans-immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction
21. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease
22. Multiple mRNA species for the precursor to an adenovirus-encoded glycoprotein: Identification and structure of the signal sequence
23. Pseudotype formation of murine leukemia virus with the G protein of vesicular stomatitis virus
24. Pathogenesis of ascites tumor growth: Angiogenesis, vascular remodeling, and stroma formation in the peritoneal lining
25. Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice
26. Prevention of carcinomatosis and bloody malignant ascites in the rat by an inhibitor of angiogenesis
27. Therapeutic effects of the angiogenesis inhibitor TNP-470 against carcinomatous peritonitis in mice
28. Effect of angiogenesis inhibitor TNP-470 on the progression of human gastric cancer xenotransplanted into nude mice
29. Angiogenesis inhibitor, TNP-470, suppresses growth of peritoneal disseminating foci
30. Inhibition of malignant ascites and growth of human ovarian carcinoma by oral administration of a potent inhibitor of the vascular endothelial growth factor receptor tyrosine kinases
31. Soluble Flt-1 gene therapy for peritoneal metastases using HVJ-cationic liposomes
32. Effects of an antibody to vascular endothelial growth factor receptor-2 on survival, tumor vascularity, and apoptosis in a murine model of colon carcinomatosis
33. Antitumoral effect of interleukin-12-secreting fibroblasts in a mouse model of ovarian cancer: Implications for the use of ovarian cancer biopsy-derived fibroblasts as a vehicle for regional gene therapy
34. Combined suicide and cytokine gene therapy for peritoneal carcinomatosis
35. The angiogenesis inhibitor, endostatin, does not affect murine cutaneous wound healing